Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...
Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...
Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without ...
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
Eli Lilly moves to defend FDA's tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy ...
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...
Later in October, the FDA said it was reassessing its decision to ban compounding pharmacies from supplying cheaper versions of Eli Lilly’s weight loss and diabetes drugs. In December ...
It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...